Protheragen Advances Gene Therapy Research with Adeno-Associated Virus (AAV) Vector Platform
Protheragen, a leading biotechnology company specializing in innovative genetic solutions, announced the expansion of its comprehensive Adeno-Associated Virus (AAV) Vector Platform services … Read more





